EGF and colorectal carcinoma: In CRC, the novel therapies that are currently used target the vascular endothelial growth factor and epidermal growth factor (EGF) signaling pathways (Kabbinavar et al, 2003; Hurwitz et al, 2004; Saltz et al, 2004).